Scientific References

As a research-active company, you can rest assured that all of the information on our website is backed by research published in a host of scientific journals. Below is the list of those articles and websites cited on our website.

  1. World Health Organisation. International Clinical Trials Registry Platform. Available from: http://apps.who.int/trialsearch/default.aspx [Accessed October 2019]. 
  2. Rogers I, Casper RF. Umbilical cord blood stem cells. Best Practice & Research Clinical Obstetrics & Gynaecology. 2004; 18(6): 893-908. 
  3. Boppart MD, De Liso M, Zou K, Huntsman HD. Defining a role for non-satellite stem cells in the regulation of muscle repair following exercise. Frontiers in Physiology. 2013; 5(4): 310.  
  4. Chamberlain CS, Saether EE, Aktas E, Vanderby R. Mesenchymal Stem Cell Therapy on Tendon/Ligament Healing. Journal of Cytokine Biology. 2017; 2(1): 112. 
  5. Rahim S, Rahim F, Shribandi K, Haghighi BB, Arjmand B. Sports Injuries: Diagnosis, Prevention, Stem Cell Therapy, and Medical Sport Strategy. In: Pham P. (eds.) Tissue Engineering and Regenerative Medicine. Advances in Experimental Medicine and Biology. Springer; 2018: 1084. 
  6. Kim SU. de Villis J. Stem cell‐based cell therapy in neurological diseases: A review. Journal of Neuroscience Research. 2009; 87(10): 2183-2200. 
  7. Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF. Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype. JAMA. 2014; 312(1):48-56. 
  8. Cancer Research UK. Leukaemia (all subtypes combined) statistics. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/leukaemia#heading-Zero [Accessed October 2019]. 
  9. Sun JM, Song AW, Case LE, Mikati MA, Gustafson KE, Simmons R, et al. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial. Stem Cells and Translational Medicine. 2017; 6: 2071–2078. 
  10. Galieva LR, Mukhamedshina YO, Arkhipova SS, Rizvanov AA. Human Umbilical Cord Blood Cell Transplantation in Neuroregenerative Strategies. Frontiers in Pharmacology; 2017; 8: Article 628. 
  11. Liu Y, Mu R, Wang S, Long L, Liu X, Li R, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Research and Therapy. 2010; 12(6): R210.  
  12. Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells and Development. 2013; 15; 22(24):3192-3202. 
  13. UKRI Medical Research Council. Regenerative Medicine. Available from: https://mrc.ukri.org/research/initiatives/regenerative-medicine/ [Accessed October 2019]. 
  14. Pham PV, Truong NC, Le PT-B, Tran TD-X, Vu NB, Bui K H-T, Phan NK. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications. Cell and Tissue Banking. 2016; 17(2): 289-302. 
  15. Squillaro T, Peluso G, Galderisi U. Clinical Trials with Mesenchymal Stem Cells: An Update. Cell Transplantation. 2016; 25(5): 829-848. 
  16. Horák J, Nalos L, Martínková V, Beneš J, Štengl M, Matějovič M. Mesenchymal Stem Cells in Sepsis and Associated Organ Dysfunction: A Promising Future or Blind Alley?. Stem Cells International. 2017; 2017: 7304121. 
  17. Mahla RS. Stem Cells Applications in Regenerative Medicine and Disease Therapeutics. International Journal of Cell Biology. 2016; 2016: 6940283. 
  18. Davies JE, Walker JT, Keating A. Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells. Stem Cells Translational Medicine. 2017; 6(7): 1620-1630.  
  19. Bi S, Nie Q, Wang WQ, Zhu YL, Ma XM, Wang CM, Zhang BC, Li HY, Zhang Q, Chen G. Human Umbilical Cord Mesenchymal Stem Cells Therapy for Insulin Resistance: A Novel Strategy in Clinical Implication. Current Stem Cell Research and Therapy. 2018; 13(8): 658-664. 
  20. Xu P, Yang X. The Efficacy and Safety of Mesenchymal Stem Cell Transplantation for Spinal Cord Injury Patients: A Meta-Analysis and Systematic Review. Cell Transplantation. 2019; 28(1): 36-46. 
  21. Saleh R, Reza HM. Short review on human umbilical cord lining epithelial cells and their potential clinical applications. Stem Cell Research and Therapy. 2017; 8:222. 
  22. Zeardast N, Lickorish D, Davies JE. Human umbilical cord perivascular cells (HUCPVC): A mesenchymal cell source for dermal wound healing. Organogenesis. 2010; 6(4): 197-203.  
  23. Park HJ, Zhang Y, Georgescu SP, Johnson KL, Kong D, Galper JB. Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis. Stem Cell Review. 2006; 2(2): 93-102. 
  24. Rogers I, Casper RF. Umbilical cord blood stem cells. Best Practice & Research Clinical Obstetrics & Gynaecology. 2004; 18(6): 893-908.  
  25. National Health Service. Stem Cells. Available from: http://www.nhsbt.nhs.uk/what-we-do/transplantation-services/stem-cells/ [Accessed October 2019] 
  26. Niederwiesser D, Pasquini MC, Aljurf MD, Confer DL, Baldomero H, Bouzas LF, et al. Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation. Blood. 2013; 122(21): 2133. 
  27. Ferrara JLM, Levine JE, Reddy P, Holler E. Graft-versus-Host Disease. Lancet. 2009; 373(9674): 1550-1561. 
  28. Ballen KK, Verter F, Kurtzberg J. Umbilical cord blood donation: public or private?. Bone Marrow Transplant. 2015; 50(10): 1271-1278. 
  29. Dawson G, Sun JM, Davlantis KS, Murias M, Franz L, Troy J, et al. Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single‐Center Phase I Open‐Label Trial. Stem Cells Translational Medicine. 2017; 6(5): 1332-1339. 
  30. Sun JM, Grant GA, McLaughlin C, Allison J, Fitzgerald A, Waters-Pick B, Kurtzberg J. Repeated autologous umbilical cord blood infusions are feasible and had no acute safety issues in young babies with congenital hydrocephalus. Pediatric Research. 2015; 78: 712-716.   
  31. Cotton CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF, et al. Feasibility of Autologous Cord Blood Cells for Infants with Hypoxic-Ischemic Encephalopathy. The Journal of Pediatrics. 2014; 164(5): 973-979. 
  32. Sun J, Allison J, McLaughlin C, Sledge L, Waters-Pick B, Wease S, Kurtzberg J. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion: Transplantation and Cellular Engineering. 2010; 50(9): 1980-1987. 
  33. Anthony Nolan Trust. ‘The Six Percent’. Available at: https://www.anthonynolan.org/how-we-help/raising-awareness/six-percent [Accessed November 2019].
  34. World Health Organisation. Optimal timing of cord clamping for the prevention of iron deficiency anaemia in infants. Available from: https://www.who.int/elena/titles/cord_clamping/en/ [Accessed October 2019].
  35. Committee on Obstetric Practice, American College of Obstetricians and Gynecologists. Committee Opinion No. 543: Timing of umbilical cord clamping after birth. Obstetrics and Gynecology. 2012; 120(6):1522-26.
  36. (3) Frändberg S, Waldner B, Konar J, Rydberg L, Fasth A, Holgersson J. High quality cord blood banking is feasible with delayed clamping practices. The eight-year experience and current status of the national Swedish Cord Blood Bank. Cell and Tissue Banking. 2016; 17(3): 439-448. 
LifeCells are based in this global centre for science,
with state-of-the-art facilities and unrivalled 24/7 security systems
LIFECELLS, Discovery Park, Sandwich, Kent CT13 9FF FIND US ON GOOGLE MAPS

NOTE! This site uses cookies and similar technologies.

Our website uses COOKIES to help improve your experience. READ MORE or ACCEPT ALL and move on.

Cookie Policy

Our Cookies Policy explains what cookies are, how we use cookies, how third-parties we may partner with may use cookies on the Service, your choices regarding cookies and further

What are cookies

Cookies are small pieces of text sent by your web browser by a website you visit. A cookie file is stored in your web browser and allows the Service or a third-party to recognize you and make your next visit easier and the Service more useful to you.

How Lifecells Ltd uses cookies

When you use and access the Service, we may place a number of cookies files in your web browser.

We use cookies for the following purposes: to enable certain functions of the Service, to provide analytics, to store your preferences, to enable advertisements delivery, including behavioural advertising.

We use both session and persistent cookies on the Service and we use different types of cookies to run the Service:
- Essential cookies. We may use essential cookies to authenticate users and prevent fraudulent use of user accounts.

For the full disclosure section, including all types of cookies, please click here.

Third-party cookies

In addition to our own cookies, we may also use various third-parties cookies to report usage statistics of the Service, deliver advertisements on and through the Service, and so on.

What are your choices regarding cookies

If you'd like to delete cookies or instruct your web browser to delete or refuse cookies, please visit the help pages of your web browser.

Please note, however, that if you delete cookies or refuse to accept them, you might not be able to use all of the features we offer, you may not be able to store your preferences, and some of our pages might not display properly.

More information about cookies

If you would like more information regarding Cookies please visit the below site:
ICO (Information Commissioner’s Office) - https://ico.org.uk/for-the-public/online/cookies/

Get your FREE GUIDE today

Our free welcome pack provides you with everything you need to start making your decision.

By providing your information, you will receive:

  • One-to-one contact with a member of our specialist support team.
  • An information pack PDF providing clear, comprehensive and unbiased information about the benefits of storing your baby’s stem cells and a step-by-step walkthrough of the collection and preservation process.

If you would like to speak to our team directly you can find our contact information here.

Invalid Input
Invalid Input
Invalid Input
Invalid Input
Invalid Input

DUE DATE:

Invalid Input
Invalid Input
Invalid Input
Invalid Input
Invalid Input
Please add customerservice@lifecells.co.uk to your contact list to ensure our emails go straight to your inbox, and check your Junk / Spam folder if you think you have not received communications from us.